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The major bacterial pathogens associated with periodontitis include Tannerella forsythia.W e
previously discovered that sialic acid stimulates biofilm growth of T. forsythia, and that sialidase
activity is key to utilization of sialoconjugate sugars and is involved in host–pathogen interactions
in vitro. The aim of this work was to assess the influence of the NanH sialidase on initial biofilm
adhesion and growth in experiments where the only source of sialic acid was sialoglycoproteins or
human oral secretions. After showing that T. forsythia can utilize sialoglycoproteins for biofilm
growth, we showed that growth and initial adhesion with sialylated mucin and fetuin were inhibited
two- to threefold by the sialidase inhibitor oseltamivir. A similar reduction (three- to fourfold) was
observed with a nanH mutant compared with the wild-type. Importantly, these data were
replicated using clinically relevant serum and saliva samples as substrates. In addition, the ability
of the nanH mutant to form biofilms on glycoprotein-coated surfaces could be restored by the
addition of purified NanH, which we show is able to cleave sialic acid from the model glycoprotein
fetuin and, much less efficiently, 9-O-acetylated bovine submaxillary mucin. These data show for
the first time that glycoprotein-associated sialic acid is likely to be a key in vivo nutrient source for
T. forsythia when growing in a biofilm, and suggest that sialidase inhibitors might be useful
adjuncts in periodontal therapy.
INTRODUCTION
The oral cavity houses a complex microbial community
capable of progressive colonization of tooth surfaces, which
can lead to the major dental diseases of caries and
periodontitis (Socransky et al., 1998). Periodontitis is a
major cause of tooth loss, affecting over 300 million people
worldwide (El-Kheshen, 2009), and bacteria associated
with periodontitis are also linked with systemic problems
such as endocarditis, atherosclerosis and predisposition
to pre-term low birth weight (Tanner & Izard, 2006).
The major bacterial pathogens associated with aggressive
periodontitis are known as the ‘red complex’, which
comprises Tannerella forsythia, Porphyromonas gingivalis
and Treponema denticola (Socransky et al., 1998). While
considerable attention has been paid to the other members
of this group, less is known of the virulence mechanisms or
physiology of T. forsythia.
Our recent work has highlighted a major role for the host
sugar sialic acid in the biofilm physiologyand host–pathogen
interactions of this key periodontal pathogen (Roy et al.,
2010). Sialic acids are commonly present as terminal sugars
on the surface of a wide variety of host glycoproteins and
eukaryotic cells (Angata & Varki, 2002; Varki, 1997). The
sialic acid residues modulate a variety of biological functions,
which include mediating cell–cell interactions, stabilizing
glycoprotein structure and masking ligand-binding receptors
(Angata & Varki, 2002; Varki, 1997; Bradshaw et al.,1 9 9 8 ) .
In addition to the identification of a novel transport system
(NanOUT), we have highlighted the role of a secreted
sialidase enzyme in acquisition of sialic acid from the
sialoconjugate sugar sialyl-lactose, which contains sialic acid
linked to galactose via an a-2,3 or a-2,6 linkage, and
furthermore to glucose via a b-1,4 linkage (Roy et al.,2 0 1 0 ) .
Sialidases are a family of glycohydrolases which cleave the
terminal sialic acid residue from sialoglycoproteins, and have
been shown to play a role in virulence for a range of patho-
gens, including Streptococcus pneumoniae and Pseudomonas
aeruginosa (Corfield, 1992; Reinholdt et al., 1990). Their
actions include inducing chemokine release from epithelial
cells (Kuroiwa et al., 2009), unmasking sialic acid-masked
epitopes for adhesion (Corfield, 1992; Tong et al.,2 0 0 0 ) ,
promoting biofilm formation (Soong et al.,2 0 0 6 ) ,a n d
Abbreviations: HRP, horseradish peroxidase; NAM, N-acetylmuraminic
acid; SNA lectin, Sambucus nigra lectin.
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et al., 1994; Byers et al.,1 9 9 9 ;K i n get al., 2006; Severi et al.,
2007). We have also shown that the T. forsythia NanH
sialidase is important in interactions with human gingival
epithelial cells (Honma etal., 2011) ina mechanism that may
expose underlying glycosyl epitopes for adhesion and
invasion. However, while interaction with host cells is clearly
an important process in periodontal pathogenesis, the ability
of periodontal bacteria to form persistent and viable biofilms
in vivo is equally pertinent.
It is well documented that the sialidase enzymes of some
pathogenic bacteria contribute to virulence, especially of
those that reside on and/or invade mucosal surfaces. This is
likely due to the abundance of sialic acid on the host
glycoproteins in these tissues (Corfield, 1992). Human
salivary glycoproteins are no exception, and contain
various complex sugar substrates such as mucin and fetuin
(Pigman & Gottschalk, 1966). Mucin contains sialic acid
linked via its terminal sugar by a 2-69 glycosidic bond to N-
acetylglucosamine (Mizan et al., 2000), whereas fetuin
contains both 2-39 and 2-69 sialic acid linkages and is more
abundant in serum, but is also found in saliva and gingival
crevicular fluid (Cointe et al., 1998). We hypothesized that
T. forsythia, like other human-dwelling bacteria, might be
able to use the sugar substrates available in the oral cavity
to obtain food and energy during the formation of dental
biofilm.
We therefore set out in this study to examine the role of the
NanH sialidase in biofilm formation using a range of
relevant model sialoprotein-coated surfaces, and thus to
begin to examine the putative in vivo substrates of this
enzyme.
METHODS
T. forsythia. T. forsythia (ATCC 43037) was routinely grown either in
liquid culture [TSB-NAM: 10% trypticase soya broth (TSB; Oxoid)
supplemented with 2% yeast extract (YE; Sigma), 1 mg haemin ml
21,
1 mg menadione ml
21 (Sigma), 10 mg N-acetylmuraminic acid ml
21
(NAM; Sigma) and 50 mg gentamicin ml
21 (Sigma)] or on Fastidious
Anaerobe agar plates (FA; Lab M) supplemented with 5% horse
blood containing 10 mg NAM ml
21 and 50 mg gentamicin ml
21.
Broth cultures and FA-NAM plates were typically incubated at 37 uC
in an anaerobic atmosphere (10% CO2,1 0 %H 2 and 80% N2) for
5 days. The sialidase mutant (DnanH) strain was grown in a similar
manner but with 5 mg erythromycin ml
21 (Honma et al., 2011).
Saliva collection. Resting whole human saliva was collected from
healthy individuals aged 25–35 years, centrifuged at 10000 g for
5 min and filter-sterilized. The supernatant was used immediately for
experiments.
Biofilm growth. T. forsythia biofilms were grown essentially as
described previously (Roy et al., 2010). Briefly, 5 day-old T. forsythia
colonies were harvested and washed twice in fresh TSB. For biofilm
growth, bacteria were inoculated to a final OD600 of 0.05 into the
supplemented TSB liquid medium in uncoated polystyrene tissue-
culture plates (Greiner) and incubated anaerobically at 37 uC for
5 days. These biofilms were grown (without NAM) either with sialic
acid (6 mM) or in the presence of the commercially available
glycoproteins bovine submaxillary gland (type I-S), mucin (6 mM,
contains 3.8 mg sialic acid, molecular mass 484 kDa), fetuin (6 mM,
contains 0.12 mg sialic acid, molecular mass 68 kDa) and asialofetuin
(6 mM, molecular mass 62 kDa) (all Sigma Aldrich). In addition,
human serum (Sigma Aldrich) or fresh whole saliva was used at a
dilution of 1:50 in PBS (~2 mgm l
21) in place of NAM or sialic acid.
The glycoproteins were coated on the 96-well tissue-culture plates
overnight at 4 uC, and then the wells were washed with PBS to wash
off excess protein.
The cell number in mature biofilms was assessed as described
previously (Roy et al., 2010); briefly, after 5 days of growth and
removal of the culture medium, samples were washed twice in sterile
PBS, followed by vigorous resuspension of biofilm cells in PBS using a
pipette, before counting microscopically using a Helber counting
chamber (Hawksley) under a phase-contrast lens (magnification
6400). The effectiveness of the harvesting method was verified by
crystal violet staining of the harvested wells to assess the number of
residual cells attached to the plate, which was usually ,0.01% (Pham
et al., 2010).
Initial attachment assay. For measurement of T. forsythia adhesion,
essentially the same conditions as for mature biofilm growth were
used, except that the assays were incubated for only 3 h at 37 uC
anaerobically. After incubation, the cells were harvested and counted
as described above.
Effect of sialidase (neuraminidase) inhibitor on biofilm growth.
The effect of the influenza virus sialidase inhibitor oseltamivir on T.
forsythia biofilm growth was assessed by its inclusion at 10 mM in the
medium, followed by the enumeration of biofilm cells after 5 days.
This concentration of inhibitor was previously established in our
laboratory as suppressing T. forsythia whole-cell sialidase activity (Roy
et al., 2010). As an alternative, siastatin B was used at a concentration
of 5 mM (which inhibits at equivalent levels to the previously utilized
oseltamivir), since during the course of this study supplies of
oseltamivir were unavailable due to the influenza pandemic.
Purification of recombinant pGEX-NanH. pGEX-nanH (this
study) was transformed into Escherichia coli BL21 and a clone was
induced using 0.1 mM IPTG. After addition of IPTG, the culture was
incubated for 3 h to express the fusion protein. The cells were
harvested by centrifugation, suspended in 200 mM phosphate buffer
(pH 7), and subjected to cell disruption by French pressure cell
(1000 p.s.i.; 6.9 MPa). The cell lysates were centrifuged at 10000 g for
10 min at 4 uC to separate the soluble fraction from the cell debris.
The recombinant fusion protein (rNanH) was purified from E. coli
lysates as described previously (Honma et al., 2011). The purified
enzyme was checked for its activity by sialidase assay, with a mean
batch activity of approximately 10–20 U.
Sialic acid release assay. Glycoproteins (6 mM) were incubated
with 0.78 mg rNanH ml
21 for 3 h at 37 uC in 50 mM sodium citrate
buffer, pH 4.5. Free sialic acid was then measured using the method
of Skoza & Mohos (1976). To ensure specificity the sialidase inhibitor
siastatin B was included as indicated above.
Direct removal of lectin-binding domains on fetuin. Fetuin
(10 mgm l
21) was incubated with various concentrations of purified
rNanH protein (0, 0.78, 1.56 and 3.12 mg ml
21) for 3 h at 37 uCi na
total volume of 30 ml 50 mM sodium citrate, pH 4.5. The samples
were then separated by 10% SDS-PAGE, transferred to nitrocellulose
membranes and incubated with a 1:1000 dilution of biotinylated
Sambucus nigra (SNA) lectin (Vector Laboratories), followed by
washing in PBS before addition of a 1:10000 dilution of a
horseradish peroxidase (HRP)–streptavidin conjugate (Sigma). The
SuperSignal West Pico chemiluminescent ECL substrate (Thermo
S. Roy and others
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Scientific) using a Tetenal developer and fixer in a Compact X4
Xograph imaging system.
Statistical analysis. Comparisons of strains for biofilm growth
and adhesion assays, and also the effects of enzyme inhibitors on
biofilm growth and adhesion assays, were analysed by Student’s
t test.
RESULTS
NanH-dependent sialidase activity is important
for biofilm growth using human glycoproteins as a
source of sialic acid
To test whether T. forsythia can obtain sialic acid from
relevant host glycoproteins for biofilm growth, 96-well
plates were pre-coated with model glycoproteins at a
similar concentration to that required for growth on free
sialic acid and sialyl-lactose (6 mM) (Roy et al., 2010). In
parallel, filter-sterilized human whole saliva from healthy
volunteers and human serum (purchased from Sigma)
were used to mimic gingival crevicular fluid, as these
represent typical secretions present in the oral cavity. Since
T. forsythia sialidase activity can be inhibited by oseltamivir
(Roy et al., 2010), we tested the effect of this inhibitor on
biofilm formation to examine whether any or all of the
growth was reliant on sialic acid.
Our previous data showed that biofilm growth on sialyl-
lactose was inhibited fivefold by oseltamivir. We now
highlighted the role of the NanH sialidase in this process,
since the nanH deletion mutant was also unable to utilize
sialyl-lactose for biofilm growth (Fig. 1). Similarly, biofilm
growth on the heavily sialylated bovine submaxillary mucin
was also reduced twofold by oseltamivir (P,0.0001) and the
nanH deletion (P,0.005) (Fig. 1). While growth on fetuin
was onlymarginallyreducedbyoseltamivir,theloss ofNanH
(in the DnanH mutant strain) caused a striking fourfold
reduction (P,0.0005). In support of this observation,
growth on asialofetuin compared with fetuin was much
lower (P,0.02). In addition, biofilm growth on asialofetuin
was higher (P,0.03) than the background when the cells
were inoculated into media lacking NAM or sialic acid as a
growthsubstrate,suggestingthatthebacteriamightuseother
sugar substrates present on asialofetuin. In order to test
whether the sialidase activity had any influence on growth in
a situation where there was a clinically relevant mixture of
glycoproteins, werepeated the experimenton surfaces coated
with human saliva and serum. Under these experimental
conditions there were statistically significant two- to
threefold reductions (in the presence of inhibitors) in growth
Fig. 1. Growth of T. forsythia biofilm on glycoprotein surfaces. (a) Biofilm growth was assessed for the wild-type strain in the
absence (black bars) or presence of oseltamivir (grey bars). Biofilms were set up in triplicate and wells were supplemented with
6 mM sialic acid (sialic) or 6 mM sialyl-lactose (sia-lac), or coated with 6 mM mucin, fetuin and asialofetuin (as-fet), 2 mg human
serum ml
”1 (serum) or saliva, with and without the addition of 10 mM oseltamivir to the TSB medium, as indicated at the time of
inoculation. Glycoproteins were coated on the 96-well plate overnight at 4 6C and washed before inoculation with T. forsythia
to a final OD600 of 0.05. Data are the mean number of cells with SDs after harvesting from wells after 5 days. Differences
between mean values in this experiment were evaluated by t test, with P,0.05 being taken as the level of significance
(*statistically significant). (b) Biofilm growth was compared as above between the wild-type (wt) strain and the DnanH mutant
strain of T. forsythia (DnanH).
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acid might be an important in vivo growth substrate.
NanH is required for efficient adhesion to
sialoglycoproteins, saliva and serum
As is the case for many biofilm-forming bacteria, the initial
adhesion to a surface is a key first step in the establishment
of a stable community, such as the dental plaque
(Kolenbrander & Palmer, 2004; Scannapieco, 1994). To
test adhesion to sialoglycoproteins, saliva and serum
bacteria were incubated with coated surfaces as for the
biofilm growth experiments, but for just 3 h.
The inclusion of 10 mM oseltamivir in the medium
resulted in reduced adherence of T. forsythia to the
glycoproteins of between two- and fivefold (P,0.05)
(Fig. 2a). demonstrating that the sialidase activity of T.
forsythia is responsible for initial attachment to model
sialylated glycoproteins (mucin and fetuin) and to the
clinically relevant protein mixtures (serum and whole
saliva). Again, adhesion to asialofetuin was lower than to
the sialylated form, and no significant reduction was
observed in the presence of the inhibitor. It is also worth
noting that the variation in absolute levels of adhesion to
different substrates may reflect differences in sialic acid
content, but could also reflect the concentration of adhered
protein, which is very difficult to estimate; nonetheless,
the consistent reductions in adhesion in the presence of
inhibitor are striking and indicate a role for sialidase in this
event. When the adhesion assays were performed with the
nanH sialidase mutant, it displayed a similar two- to
fivefold reduction in attachment to the glycoproteins
compared with the wild-type strain (Fig. 2b).
Ideally, a genetic complementation experiment would be
carried out in which the wild-type nanH gene was
reintroduced into the nanH mutant strain. However, to
date, no one has yet developed a genetic complementation
system for T. forsythia. Therefore we used purified rNanH
protein in an enzyme complementation study (Honma
et al., 2011). In these experiments the nanH deletion was
incubated with glycoprotein-coated surfaces and cell
attachment was assayed. Fig. 3 shows a statistically
significant increase (P,0.05) in adhesion of between 1.5-
and twofold in the presence of rNanH. This confirms that
NanH is essential for initial attachment to the glycopro-
teins present in host cells or in the oral environment.
NanH can directly release sialic acid from
glycoproteins
In order to more fully characterize the role of NanH in
release of sialic acid from a range of glycoproteins, we
Fig. 2. Initial attachment of T. forsythia to glycoprotein-coated surfaces. (a) Adhesion to glycoproteins was assessed for the
wild-type strain in the absence (black bars) or presence of oseltamivir (grey bars). Biofilms were set up in triplicate and wells
were supplemented with 6 mM sialic acid (sialic), or were coated with 6 mM mucin, fetuin and asialofetuin (as-fet), 2 mg human
serum ml
”1 (serum) or saliva, with and without the addition of 10 mM oseltamivir to the TSB medium, as indicated at the time of
inoculation. Glycoproteins were coated on the 96-well plate overnight at 4 6C and washed before inoculation with T. forsythia
to a final OD600 of 0.05. Data are the mean number of cells with SDs after harvesting from wells after 3 h. Differences between
mean values in this experiment were evaluated by t test, with P,0.05 being taken as the level of significance (*statistically
significant). (b) Adhesion to glycoproteins was compared as above between the wild-type (wt) strain and DnanH mutant strain
of T. forsythia (DnanH).
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2011). After purification, the rNanH enzyme (0.78 mg
ml
21) was incubated with 6 mM fetuin and mucin for 3 h
at 37 uC. The release of sialic acid from these proteins was
then assessed using the thiobarbiturate assay of Skoza &
Mohos (1976). Fig. 4 illustrates that in addition to cleavage
of the 4-methylumbelliferyl substrate, we have now shown,
to our knowledge for the first time, that rNanH can cleave
sialic acid from the sialylated glycoprotein fetuin (Fig. 4,
column 1) with the release of 30 nM sialic acid min
21 (mg
protein)
21. Furthermore, we showed that this is inhibitable
by the sialidase inhibitor siastatin B, indicating that this
is a sialic acid-specific activity. When this enzyme was
incubated with the same concentration of mucin (6 mM
bovine submaxillary) (Fig. 4, column 4) we also observed a
release of sialic acid. This result was somewhat surprising,
since Thompson et al. (2009) reported that they could not
detect release of sialic acid from mucin using rNanH-
expressing lysates of E. coli. However, the concentration of
mucin used in this assay (6 mM) contained approximately
32-fold more sialic acid than the equivalent concentration
of fetuin. In contrast, if rNanH was incubated with
0.002 mM mucin, which contained the equivalent amount
of sialic acid (0.48 mgm l
21) as fetuin, there was almost no
release of sialic acid (Fig. 4, column 3).
In order to further confirm our observation that rNanH
can release sialic acid from physiologically relevant
substrates, we probed the glycoprotein fetuin that had
been pretreated with rNanH for the presence of the epitope
for the sialic acid-specific biotinylated SNA lectin, which
was detected with streptavidin–HRP. The SNA lectin binds
preferentially to sialic acid linked to terminal galactose in
a-2,6 and to a lesser extent a-2,3 linkages, both of which are
contained in fetuin. Fig. 5 shows that in the absence of
rNanH (lane 1), the fetuin band can clearly be seen at
68 kDa. However, after the treatment of fetuin with
increasing concentrations of purified rNanH, the lectin-
binding site was removed and the fetuin-specific band
disappeared from the blots (Fig. 5). These data support our
findings using the thiobarbituric acid assay, and dem-
onstrate for the first time to our knowledge that T. forsythia
NanH can cleave both a-2,6- and a-2,3-linked sialic acid
directly from glycoproteins.
DISCUSSION
Our previous work identified that the fastidious anaerobe
T. forsythia is able to utilize sialic acid as a growth factor to
stimulate its biofilm growth, and that it possesses a novel
Fig. 3. Adhesion of the DnanH mutant strain of T. forsythia to
glycoprotein surfaces without (black bars) and with purified NanH
(rNanH) (grey bars). Biofilms were set up in triplicate and wells
were supplemented with 6 mM sialic acid (sialic) or 6 mM sialyl-
lactose (sia-lac) to the TSB medium, or were coated with 6 mM
mucin, fetuin and asialofetuin (as-fet), 2 mg human serum ml
”1
(serum) or saliva, as indicated at the time of inoculation.
Glycoproteins were coated on the 96-well plate overnight at
4 6C and washed before inoculation with T. forsythia to a final
OD600 of 0.05. Data are the number of cells with SDs after
harvesting from wells after 3 h. Differences between mean values
in this experiment were evaluated by t test, with P,0.05 being
taken as the level of significance (*statistically significant).
Fig. 4. Release of free sialic acid from glycoprotein by recombinant
NanH (rNanH). Six millimolar fetuin [0.48 mg sialic acid ml
”1, fetuin
(0.48)], 0.002 mM mucin [0.48 mg sialic acid ml
”1, mucin (0.48)]
or 6 mM mucin [19 mg sialic acid ml
”1, mucin (19)] was incubated
in the presence (white bars) and absence (grey bars) of 5 mM of
the sialidase inhibitor siastatin B (+sias) at 37 6C for 3 h. A549
was measured after colour development (*statistically significant at
P,0.05).
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also shown that the sialidase activity of T. forsythia is
important for sialic acid acquisition from the common
glycosyl mimic sialyl-lactose (Roy et al., 2010). In other
work we have established that the NanH sialidase is
involved in adhesion to and invasion into gingival
epithelial cells (Honma et al., 2011). We now report that
the NanH sialidase is key to the initial formation and
growth of biofilms on glycoprotein-coated surfaces, where
the only source of sialic acid was conjugated to glycopro-
teins as a-2,3 or 2,6 linkages to galactose or glucose. This is
particularly pertinent given the environmental niche that
T. forsythia inhabits in the oral cavity, where there is an
abundance of sialic acid-containing glycoproteins that
include fibronectin, integrins, gangliosides and mucins,
both in secretions and contained on the surface of oral
epithelial cells (Gabriel et al., 2005; Byres et al., 2008;
Martin et al., 2005; Offner & Troxler, 2000; Dabelsteen,
1996). The role of sialidases in the release of nutritionally
available sialic acid is similar to the strategy of several
human-dwelling bacteria in mucin-rich environments,
such as the intestinal (Bacteroides fragilis and Vibrio
cholerae) and respiratory tracts (S. pneumoniae) (Corfield,
1992).
Our data highlight roles for conjugated sialic acid both as a
source of nutrition and as a receptor in the initial stages
of biofilm formation on glycoprotein-coated surfaces, a
situation which may mimic in vivo conditions in which
inert and cellular surfaces are coated in a layer of mucus
(Derrien et al., 2010). While binding of oral bacteria such
as Streptococcus gordonii and Streptococcus sanguis to the
sialic acid in mucin has been documented in the past
(Demuth et al., 1990; Takahashi et al., 2002, 2004), we
believe that this is the first indication that a Gram-negative
periodontal pathogen also possesses such an activity.
Our finding that both sialidase inhibitors and deletion
of the sialidase gene affect adhesion to glycoproteins
suggests that three separate mechanisms may be occurring
simultaneously to achieve adhesion: (1) the sialidase itself
acts as a lectin-like adhesin (Banerjee et al., 2010), perhaps
via the 170 aa N-terminal region; (2) the sialidase causes
exposure of the underlying glucose and galactose residues
to which the bacteria bind; (3) there is a two-stage
mechanism in which sialic acid is key to the initial stages of
adhesion but in which underlying sugars may be involved
in more stable interactions. This is the case for some other
pathogens, in which desialylated glycolipids can act as
receptors for pathogenic bacteria, including S. pneumoniae
and Pseudomonas aeruginosa, which bind to exposed
GalNAcb1-4Gal residues when sialic acid is removed
(Krivan et al., 1988). Taken overall and in light of our
previous work showing the importance of sialidase and
sialic acid in adhesion to host cells, it seems that in vivo
desialylation of host molecules is crucial to T. forsythia.
Recent evidence from the Fletcher laboratory has high-
lighted that this may also be the case for the other major
periodontal pathogen P. gingivalis, in which mutations in
a putative sialidase and two sialyl-endopeptidases affect
adhesion to HeLa cells (Aruni et al., 2011); however, at
present there is no evidence regarding their role in biofilm
formation in P. gingivalis. Similarly, in the oral setting, the
sialidase activity of several Streptococcus spp. can also result
in exposure of galactose residues, enhancing the attach-
ment of bacteria that possess galactosyl-binding adhesins,
e.g Fusobacterium spp. (Falkler & Burger, 1981) and
Actinomyces viscosus (Ellen et al., 1980). It now seems
possible that T. forsythia may also play such a role.
While the role of sialidase in T. forsythia adhesion and
nutrition seems well established, like many members of
the Bacteroidetes, T. forsythia possesses a plethora of
glycosidase and sugar-focussed metabolic capabilities. For
example T. forsythia possesses at least three putative beta-
hexosaminidase-encoding genes (TF0036, TF2925 and
TF0014), which may possess the ability to remove terminal
galactose and glucose sugars from glycoproteins that are
exposed after removal of sialic acid (Spiro & Bhoyroo,
1974; Salyers et al., 1988). However, at present, the role of
these enzymes in the biofilm lifestyle of T. forsythia is
unknown.
The action of sialidase may also have nutritional con-
sequences for other oral biofilm inhabitants; for example,
S. oralis releases sialic acid from a1-acid glycoproteins
(AGPs), which are then utilized by other bacteria (Byers
et al., 1999). Similarly, after the removal of sialic acid from
fetuin and mucin, subsequent removal of galactose and
glucose can be used by bacteria as a carbon and nitrogen
source (Leake & Read, 1990). Indeed, this may be the case
for T. forsythia, since subgingival plaque is made up of
several species with the ability to use sialic acid and other
sugars, while T. forsythia itself probably cannot.
In addition to our experiments highlighting adhesion to
and biofilm growth upon glycoprotein-coated surfaces, we
also showed by biochemical and lectin-binding assays that
the rNanH enzyme releases a-2,6-linked sialic acid from
Fig. 5. Removal of lectin-binding moieties by rNanH. Fetuin at
10 mgm l
”1 was incubated with increasing concentrations of
rNanH (0, 0.78 and 1.5 mg ml
”1) for 3 h before running on an
SDS-PAGE gel, blotting onto a nitrocellulose membrane, probing
with 5 mgm l
”1 biotinylated SNA lectin, and visualizing with
streptavidin–HRP and luminescent substrate, before incubation
with X-ray film. Clostridium tetani sialidase (Cl-sia) (50 U) was
used as a positive control, with asialofetuin (as-fet) and 1.5 mg
rNanH ml
”1 as negative controls.
S. Roy and others
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been shown to preferentially cleave sialic acid from 2,6
sialyl-lactose in vitro. Our finding that sialic acid release
from the a-2,3- and a-2,6-linked but largely 9-O-acetylated
sialic acid contained in mucin was much less efficient is
also in keeping with earlier findings, since this chemical
group is known to inhibit bacterial sialidases (Thompson
et al., 2009).
However, our data show that T. forsythia is able to grow as
a biofilm on mucin-coated surfaces and indicate that it is
thus able to remove the 9-O-acetyl group from the sialic
acid contained on the surface of mucin (Fig. 4). This is
probably due to the activity of a putative secreted 9-O-
acetylesterase encoded by the TF0037 gene, and may play a
crucial role in vivo in the mucin-rich oral environment that
T. forsythia inhabits. In the gut bacterium E. coli, mutation
of a recently identified sialate-O-acetyl esterase, nanS,
results in abolition of its ability to use 9-O-acetylated sialic
acid as a sole carbon and energy source. However, the
NanS of E. coli, which does not possess a secreted sialidase,
is a predicted periplasmic protein that probably acts to
process Neu5,9Ac during sialic acid uptake (Steenbergen
et al., 2009). In contrast, the putative NanS of T. forsythia is
likely to be secreted into the extracellular milieu, where it
could help with scavenging of sialic acid from host sources.
Overall, our findings indicate that sialoglycoproteins are
important substrates for biofilm formation and attachment
of T. forsythia to oral surfaces in vivo. In addition, this
study raises the possibility that oseltamivir or siastatin B
might be used as alternative drug therapies for reduction of
dental plaque biofilms.
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